Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$290M
$139,000 0.0% of portfolio
38,384
Q2 2025 Added 0.63%
Tempus Ai Inc
-
$6.83 Million 0.0% of portfolio
-
Q2 2025 Added 42.57%
$21.9B
$0 0.0% of portfolio
1
Q2 2025 Reduced 100.0%
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$77.8M
$6,000 0.0% of portfolio
9,537
Q2 2025 Reduced 84.02%
$1.5B
$2.74 Million 0.0% of portfolio
35,316
Q2 2025 Added 8.11%
$2.14B
$2.12 Million 0.0% of portfolio
95,181
Q2 2025 Reduced 52.63%
$1.64B
$2.31 Million 0.0% of portfolio
526,727
Q2 2025 Added 11.14%
$3.74B
$7.96 Million 0.0% of portfolio
170,438
Q2 2025 Added 49.78%
$7.35B
$0 0.0% of portfolio
1
Q2 2025 Reduced 99.98%
$305M
$912,000 0.0% of portfolio
244,637
Q2 2025 Reduced 62.54%
$1.79B
$8.38 Million 0.0% of portfolio
232,942
Q2 2025 Reduced 4.74%
Tetra Tech Inc New
-
$2.47 Million 0.0% of portfolio
-
Q2 2025 Reduced 16.87%
$939M
$726,000 0.0% of portfolio
216,390
Q2 2025 Added 31.28%
$21.8B
$10.1 Million 0.0% of portfolio
600,014
Q2 2025 Reduced 21.45%
Tevogen Bio Hldgs Inc
-
$86,000 0.0% of portfolio
-
Q2 2025 Added 80.16%
$7.8B
$9.55 Million 0.0% of portfolio
106,539
Q2 2025 Added 67.23%
$3.71B
$434,000 0.0% of portfolio
33,503
Q2 2025 Added 22.4%
$79.1M
$149,000 0.0% of portfolio
24,011
Q2 2025 New
$2.41B
$6.42 Million 0.0% of portfolio
149,890
Q2 2025 Added 31.15%
$210M
$383,000 0.0% of portfolio
200,512
Q2 2025 Added 148.25%
$1.35B
$3.9 Million 0.0% of portfolio
214,958
Q2 2025 Added 5.73%
$306M
$213,000 0.0% of portfolio
103,670
Q2 2025 New
$82.9M
$67,000 0.0% of portfolio
16,657
Q2 2025 Reduced 57.25%
$716M
$878,000 0.0% of portfolio
194,792
Q2 2025 Added 68.29%
$1.18B
$926,000 0.0% of portfolio
193,519
Q2 2025 Added 55.22%
Theratechnologies Inc
-
$1,000 0.0% of portfolio
-
Q2 2025 New
$956M
$1.45 Million 0.0% of portfolio
131,802
Q2 2025 Added 153.3%
$899M
$2.06 Million 0.0% of portfolio
73,445
Q2 2025 Added 56.59%
$532M
$725,000 0.0% of portfolio
22,203
Q2 2025 Added 82.65%
$217M
$309,000 0.0% of portfolio
56,905
Q2 2025 Added 62.44%
Thomson Reuters Corp
-
$16.7 Million 0.0% of portfolio
-
Q2 2025 Reduced 12.79%
$5.62B
$2.35 Million 0.0% of portfolio
26,429
Q2 2025 Reduced 67.41%
$601M
$1.2 Million 0.0% of portfolio
159,810
Q2 2025 Added 100.2%
$404M
$925,000 0.0% of portfolio
76,151
Q2 2025 Added 35.86%
$2.18B
$4.35 Million 0.0% of portfolio
94,318
Q2 2025 Added 64.57%
$328M
$317,000 0.0% of portfolio
49,963
Q2 2025 Added 63.26%
$40.8M
$2,000 0.0% of portfolio
1,772
Q2 2025 Reduced 89.2%
$960M
$136,000 0.0% of portfolio
329,006
Q2 2025 Added 21.24%
$10.7B
$336,000 0.0% of portfolio
16,695
Q1 2025 Reduced 34.36%
$264M
$710,000 0.0% of portfolio
22,757
Q2 2025 Added 30.93%
$5.46B
$7.76 Million 0.0% of portfolio
106,892
Q2 2025 Added 121.04%
$639M
$1.83 Million 0.0% of portfolio
77,603
Q2 2025 Added 20.28%
Titan Amer Sa
-
$552,000 0.0% of portfolio
-
Q2 2025 New
$467M
$1.19 Million 0.0% of portfolio
115,925
Q2 2025 Added 40.02%
$350M
$686,000 0.0% of portfolio
34,680
Q2 2025 Added 64.63%
$2.1B
$411,000 0.0% of portfolio
62,263
Q2 2025 Added 329.64%
$941M
$1.81 Million 0.0% of portfolio
28,780
Q2 2025 Added 55.21%
Tonix Pharmaceuticals Hldg C
-
$478,000 0.0% of portfolio
-
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email